GlassScriptPhysician profile
Luis Villani
NPI 1962498782
$2,651.71
in general payments reported to CMS, 2019-2025
17 companies · $326 in 2025
The $326 reported for 2025 was less than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $375 · 2020: $318 · 2021: $309 · 2022: $434 · 2023: $271 · 2024: $619 · 2025: $326.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,215.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,215.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $599.92 | 2019-2025 | Clareon, Clareon Panoptix Pro, Simbrinza |
| Allergan, INC. | $471.98 | 2019-2022 | |
| Abbvie INC. | $388.84 | 2022-2025 | Lumigan, Vuity, Alphagan P |
| Novartis Pharmaceuticals Corporation | $244.25 | 2019-2023 | |
| Glaukos Corporation | $184.15 | 2024 | Idose |
| Aerie Pharmaceuticals, INC. | $170.58 | 2019-2021 | |
| Sun Pharmaceutical Industries INC. | $135.66 | 2019-2022 | |
| Kala Pharmaceuticals, INC. | $129.14 | 2019-2021 | |
| Oyster Point Pharma, INC. | $89.57 | 2022-2023 | Tyrvaya |
| Bausch & Lomb Americas INC. | $52.92 | 2024-2025 | Xiidra, Miebo |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $49.03 | 2019-2021 | |
| Harrow Eye, LLC | $25.68 | 2024 | Vevye |
| Astellas Pharma US INC | $24.91 | 2024 | Izervay |
| Amgen INC. | $24.06 | 2024 | Tepezza |
| Horizon Therapeutics Plc | $22.75 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biotissue Holdings INC. | $22.28 | 2021 | |
| Sight Sciences, INC. | $15.99 | 2023 | Tearcare System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Luis Villani listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.